GB202011431D0 - Polymorphs of vadadustat and methods for preparing the polymorphs - Google Patents

Polymorphs of vadadustat and methods for preparing the polymorphs

Info

Publication number
GB202011431D0
GB202011431D0 GBGB2011431.0A GB202011431A GB202011431D0 GB 202011431 D0 GB202011431 D0 GB 202011431D0 GB 202011431 A GB202011431 A GB 202011431A GB 202011431 D0 GB202011431 D0 GB 202011431D0
Authority
GB
United Kingdom
Prior art keywords
polymorphs
vadadustat
preparing
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2011431.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johnson Matthey PLC
Original Assignee
Johnson Matthey PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson Matthey PLC filed Critical Johnson Matthey PLC
Priority to GBGB2011431.0A priority Critical patent/GB202011431D0/en
Publication of GB202011431D0 publication Critical patent/GB202011431D0/en
Priority to PCT/GB2021/051899 priority patent/WO2022018450A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/02—Salts; Complexes; Addition compounds
GBGB2011431.0A 2020-07-23 2020-07-23 Polymorphs of vadadustat and methods for preparing the polymorphs Ceased GB202011431D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2011431.0A GB202011431D0 (en) 2020-07-23 2020-07-23 Polymorphs of vadadustat and methods for preparing the polymorphs
PCT/GB2021/051899 WO2022018450A1 (en) 2020-07-23 2021-07-22 Crystalline forms of vadadustat and methods for their preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2011431.0A GB202011431D0 (en) 2020-07-23 2020-07-23 Polymorphs of vadadustat and methods for preparing the polymorphs

Publications (1)

Publication Number Publication Date
GB202011431D0 true GB202011431D0 (en) 2020-09-09

Family

ID=72339400

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2011431.0A Ceased GB202011431D0 (en) 2020-07-23 2020-07-23 Polymorphs of vadadustat and methods for preparing the polymorphs

Country Status (2)

Country Link
GB (1) GB202011431D0 (en)
WO (1) WO2022018450A1 (en)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO2686520T3 (en) * 2011-06-06 2018-03-17
WO2015073779A1 (en) * 2013-11-15 2015-05-21 Akebia Therapeutics, Inc. Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
KR20190093651A (en) 2016-12-13 2019-08-09 크리스탈 파마슈티컬 (쑤저우) 씨오., 엘티디. Novel crystalline forms of ((5- (3-chlorophenyl) -3-hydroxypyridine-2-carbonyl) amino) acetic acid and preparation methods thereof
MX2020011845A (en) * 2018-05-09 2021-01-15 Akebia Therapeutics Inc Process for preparing 2-[[5-(3-chlorophenyl)-3-hydroxypyridine-2- carbonyl]amino]acetic acid.
WO2020075199A1 (en) * 2018-10-12 2020-04-16 Mylan Laboratories Limited Polymorphic forms of vadadustat
CN111848505A (en) * 2019-04-26 2020-10-30 广东东阳光药业有限公司 Preparation method of vatacostat intermediate
US11524939B2 (en) * 2019-11-13 2022-12-13 Akebia Therapeutics, Inc. Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid
WO2021117767A1 (en) * 2019-12-10 2021-06-17 田辺三菱製薬株式会社 Method for producing nitrogen-containing heteroarylcarboxamide acetic acid derivative

Also Published As

Publication number Publication date
WO2022018450A1 (en) 2022-01-27

Similar Documents

Publication Publication Date Title
IL292754A (en) Method of synthesis
IL271938A (en) Method for the preparation of synthesis gas
IL271939A (en) Method for the preparation of synthesis gas
IL271941A (en) Method for the preparation of synthesis gas
EP3712130A4 (en) Method for synthesis of roxadustat and intermediate compounds thereof
IL292648A (en) Process for the preparation of glucuronide drug-linkers and intermediates thereof
EP3611171A4 (en) Method for synthesis of eliglustat and intermediate compounds thereof
ZA202101214B (en) Process and intermediates for the preparation of bilastine
ZA202101837B (en) Method for the preparation of synthesis gas
EP3728241A4 (en) Process for the preparation of opicapone and intermediates thereof
IL289453A (en) Process for the preparation of ridinilazole and crystalline forms thereof
IL281254A (en) Process for the preparation of lenvatinib
HUE058259T2 (en) Process for the preparation of lubiprostone and intermediates thereof
PL3737685T3 (en) Process for the preparation of crisaborole and its intermediates
GB201915447D0 (en) Polymorphs of avapritinib and methods of preparing the polymorphs
IL290169A (en) Process and intermediates for the preparation of pyroxasulfone
IL289904A (en) Process for the preparation of biphenylamines
GB202011431D0 (en) Polymorphs of vadadustat and methods for preparing the polymorphs
ZA202107053B (en) Novel process for the preparation of filgotinib and intermediates thereof
HUE062114T2 (en) Processes for preparing alpha-necrodyl compounds and processes for preparing gamma-necrodyl compounds
GB201903055D0 (en) Method of oligonucleaotide synthesis
EP3877361C0 (en) Process for the preparation of arylsulfonylpropenenitriles
GB201911627D0 (en) Polymorph of venetoclax and method for preparing the polymorph
HUP2100077A1 (en) Process for the preparation of avapritinib and intermediates for the process
PT3969459T (en) Process and intermediates for the preparation of eldecalcitol

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)